Phototherapeutic keratectomy for epithelial basement membrane dystrophy

Wen-Shin Lee, Carson K Lam, Edward E Manche Department of Ophthalmology, Stanford University, Stanford, CA, USA Purpose: The purpose of this study was to evaluate the long-term efficacy of phototherapeutic keratectomy (PTK) in treating epithelial basement membrane dystrophy (EBMD).Methods: Preoper...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lee WS, Lam CK, Manche EE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
PTK
Acceso en línea:https://doaj.org/article/5bf16332a1cf4fb3a9c385b4319abd71
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5bf16332a1cf4fb3a9c385b4319abd71
record_format dspace
spelling oai:doaj.org-article:5bf16332a1cf4fb3a9c385b4319abd712021-12-02T01:00:23ZPhototherapeutic keratectomy for epithelial basement membrane dystrophy1177-5483https://doaj.org/article/5bf16332a1cf4fb3a9c385b4319abd712016-12-01T00:00:00Zhttps://www.dovepress.com/phototherapeutic-keratectomy-for-epithelial-basement-membrane-dystroph-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Wen-Shin Lee, Carson K Lam, Edward E Manche Department of Ophthalmology, Stanford University, Stanford, CA, USA Purpose: The purpose of this study was to evaluate the long-term efficacy of phototherapeutic keratectomy (PTK) in treating epithelial basement membrane dystrophy (EBMD).Methods: Preoperative and postoperative records were reviewed for 58 eyes of 51 patients with >3 months follow-up (range 3−170 months) treated for EBMD with PTK after failure of conservative medical treatment at Byers Eye Institute of Stanford University. Symptoms, clinical findings, and corrected distance visual acuity (CDVA) were assessed. The primary outcome measure was symptomatic recurrence as measured by erosions or visual complaints >3 months after successful PTK.Results: For eyes with visual disturbances (n=30), preoperative CDVA was ~20/32 (0.24 LogMAR, SD 0.21) and postoperative CDVA was ~20/25 (0.07 LogMAR, SD 0.12; P<0.0001). Twenty-six eyes (86.7%) responded to treatment, with symptomatic recurrence in 6 eyes (23.1%) at an average of 37.7 months (SD 42.8). For eyes with painful erosions (n=29), preoperative CDVA was ~20/25 (0.12, SD 0.19) and postoperative CDVA was ~20/20 (0.05. SD 0.16; P=0.0785). Twenty-three eyes (79.3%) responded to treatment, with symptomatic recurrence in 3 eyes (13.0%) at an average of 9.7 months (SD 1.5). The probability of being recurrence free after a successful treatment for visual disturbances and erosions at 5 years postoperatively was estimated at 83.0% (95% confidence interval 68.7%–97.0%) and 88.0% (95% confidence interval 65.3%–96.6%), respectively.Conclusion: The majority of visual disturbances and painful erosions associated with EBMD respond to PTK. For those with a treatment response, symptomatic relief is maintained over long-term follow-up. Keywords: epithelial basement membrane dystrophy, EBMD, phototherapeutic keratectomy, PTKLee WSLam CKManche EEDove Medical PressarticleEpithelial Basement Membrane DystrophyEBMDPhototherapeutic KeratectomyPTKOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 15-22 (2016)
institution DOAJ
collection DOAJ
language EN
topic Epithelial Basement Membrane Dystrophy
EBMD
Phototherapeutic Keratectomy
PTK
Ophthalmology
RE1-994
spellingShingle Epithelial Basement Membrane Dystrophy
EBMD
Phototherapeutic Keratectomy
PTK
Ophthalmology
RE1-994
Lee WS
Lam CK
Manche EE
Phototherapeutic keratectomy for epithelial basement membrane dystrophy
description Wen-Shin Lee, Carson K Lam, Edward E Manche Department of Ophthalmology, Stanford University, Stanford, CA, USA Purpose: The purpose of this study was to evaluate the long-term efficacy of phototherapeutic keratectomy (PTK) in treating epithelial basement membrane dystrophy (EBMD).Methods: Preoperative and postoperative records were reviewed for 58 eyes of 51 patients with >3 months follow-up (range 3−170 months) treated for EBMD with PTK after failure of conservative medical treatment at Byers Eye Institute of Stanford University. Symptoms, clinical findings, and corrected distance visual acuity (CDVA) were assessed. The primary outcome measure was symptomatic recurrence as measured by erosions or visual complaints >3 months after successful PTK.Results: For eyes with visual disturbances (n=30), preoperative CDVA was ~20/32 (0.24 LogMAR, SD 0.21) and postoperative CDVA was ~20/25 (0.07 LogMAR, SD 0.12; P<0.0001). Twenty-six eyes (86.7%) responded to treatment, with symptomatic recurrence in 6 eyes (23.1%) at an average of 37.7 months (SD 42.8). For eyes with painful erosions (n=29), preoperative CDVA was ~20/25 (0.12, SD 0.19) and postoperative CDVA was ~20/20 (0.05. SD 0.16; P=0.0785). Twenty-three eyes (79.3%) responded to treatment, with symptomatic recurrence in 3 eyes (13.0%) at an average of 9.7 months (SD 1.5). The probability of being recurrence free after a successful treatment for visual disturbances and erosions at 5 years postoperatively was estimated at 83.0% (95% confidence interval 68.7%–97.0%) and 88.0% (95% confidence interval 65.3%–96.6%), respectively.Conclusion: The majority of visual disturbances and painful erosions associated with EBMD respond to PTK. For those with a treatment response, symptomatic relief is maintained over long-term follow-up. Keywords: epithelial basement membrane dystrophy, EBMD, phototherapeutic keratectomy, PTK
format article
author Lee WS
Lam CK
Manche EE
author_facet Lee WS
Lam CK
Manche EE
author_sort Lee WS
title Phototherapeutic keratectomy for epithelial basement membrane dystrophy
title_short Phototherapeutic keratectomy for epithelial basement membrane dystrophy
title_full Phototherapeutic keratectomy for epithelial basement membrane dystrophy
title_fullStr Phototherapeutic keratectomy for epithelial basement membrane dystrophy
title_full_unstemmed Phototherapeutic keratectomy for epithelial basement membrane dystrophy
title_sort phototherapeutic keratectomy for epithelial basement membrane dystrophy
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/5bf16332a1cf4fb3a9c385b4319abd71
work_keys_str_mv AT leews phototherapeutickeratectomyforepithelialbasementmembranedystrophy
AT lamck phototherapeutickeratectomyforepithelialbasementmembranedystrophy
AT mancheee phototherapeutickeratectomyforepithelialbasementmembranedystrophy
_version_ 1718403384696897536